| Quartile of HOMA-IR | |||||
---|---|---|---|---|---|---|
 | Overall | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4a | Quartile 4b |
Event: Composite Renal Endpoint (ESRD/Halving of eGFR) | ||||||
 Sample size | 1883 | 471 | 471 | 471 | 235 | 235 |
 # of events | 474 | 114 | 109 | 126 | 64 | 61 |
 Median (IQR) follow up, years | 7.76 (3.40–10.26) | 7.65 (3.06–10.30) | 7.88 (3.24–10.35) | 7.76 (3.93–10.18) | 7.30 (3.57–10.03) | 7.84 (3.32–10.16) |
 Event rate per 100 person-years (95% CI) | 3.68 (3.37–4.03) | 3.55 (2.96–4.27) | 3.39 (2.81–4.09) | 3.85 (3.23–4.58) | 4.08 (3.20–4.58) | 3.80 (2.96–4.88) |
Event: Composite Atherosclerotic CVD Endpoint (MI/PAD/stroke) | ||||||
 Sample size | 1883 | 471 | 471 | 471 | 235 | 235 |
 # of events | 220 | 47 | 53 | 55 | 33 | 32 |
 Median (IQR) follow up, years | 9.43 (5.95–10.81) | 9.41 (6.14–10.90) | 9.51 (5.86–10.70) | 9.45 (7.03–10.87) | 9.51 (6.10–10.70) | 9.23 (5.43–10.59) |
 Event rate per 100 person-years (95% CI) | 1.43 (1.25–1.63) | 1.22 (0.92–1.62) | 1.38 (1.05–1.80) | 1.39 (1.07–1.82) | 1.73 (1.23–2.43) | 1.72 (1.22–2.44) |
Event: All-Cause Mortality | ||||||
 Sample size | 1883 | 471 | 471 | 471 | 235 | 235 |
 # of events | 379 | 96 | 90 | 98 | 44 | 51 |
 Median (IQR) follow up, years | 10.15 (8.74–11.09) | 10.18 (8.66–11.10) | 10.00 (8.66–11.02) | 10.25 (8.83–11.14) | 10.21 (8.98–11.05) | 9.74 (8.60–11.01) |
 Event rate per 100 person-years (95% CI) | 2.19 (1.98–2.42) | 2.21 (1.81–2.71) | 2.11 (1.72–2.60) | 2.23 (1.83–2.72) | 2.00 (1.49–2.69) | 2.40 (1.83–3.16) |